BioMarin Loss Narrower Than Estimates

(RTTNews) - BioMarin Pharmaceutical Inc (BMRN) on Wednesday reported fourth-quarter net loss of $69.8 million or $0.47 per share compared with a loss of $62 million or $0.44 per share last year.

Excluding items, adjusted loss for the quarter was $0.08 per share compared with a loss of $0.11 per share a year ago.

Revenues for the quarter surged 57% to $230.9 million from $146.9 million in the prior year.

Analysts polled by Thomson Reuters estimated a loss of $0.59 per share on revenues of $189.5 million for the quarter. Analysts' estimates typically exclude special items.

Total expenses for the quarter rose to $289.6 million from $199 million, the company said.

For the full year 2015, the company expects adjusted loss of $170 million to $130 million and revenues of $840 million to $870 million.

Analysts expect a loss of of $2.00 per share on revenues of $880.6 million for 2015.